Marta Campos Campos

Ms. Marta Campos Campos

Heidelberg University Hospital
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
JMJakob Morgenstern
Jakob Morgenstern
MCMarta Campos Campos
Marta Campos Campos
PNPeter Nawroth
Peter Nawroth
TFThomas Fleming
Thomas Fleming
The glyoxalase system was discovered over a hundred years ago and since then it has been claimed to provide the role of an indispensable enzyme system in order to protect cells from a toxic byproduct of glycolysis. This review gives a broad overview of what has been postulated in the last 30 years of glyoxalase research, but within this context it also challenges the concept that the glyoxalase system is an exclusive tool of detoxification and that its substrate, methylglyoxal, is solely a detrimental burden for every living cell due to its toxicity. An overview of consequences of a complete loss of the glyoxalase system in various model organisms is presented with an emphasis on the role of alternative detoxification pathways of methylglyoxal. Furthermore, this review focuses on the overlooked posttranslational modification of Glyoxalase 1 and its possible implications for cellular maintenance under various (patho-)physiological conditions. As a final note, an intriguing point of view for the substrate methylglyoxal is offered, the concept of methylglyoxal (MG)-mediated hormesis.

1 September 2020 in Cell Reports
Verified
Journal Article
Open access
JMJakob Morgenstern
Jakob Morgenstern
SKSylvia Katz
Sylvia Katz
JKJutta Krebs-Haupenthal
Jutta Krebs-Haupenthal
JCJessy Chen
Jessy Chen
ASAlireza Saadatmand
Alireza Saadatmand
TFThomas Fleming
Thomas Fleming
The glyoxalase system is a highly conserved and ubiquitously expressed enzyme system, which is responsible for the detoxification of methylglyoxal (MG), a spontaneous by-product of energy metabolism. This study is able to show that a phosphorylation of threonine-107 (T107) in the (rate-limiting) Glyoxalase 1 (Glo1) protein, mediated by Ca2+/calmodulin-dependent kinase II delta (CamKIIδ), is associated with elevated catalytic efficiency of Glo1 (lower KM; higher Vmax). Additionally, we observe proteasomal degradation of non-phosphorylated Glo1 via ubiquitination does occur more rapidly as compared with native Glo1. The absence of CamKIIδ is associated with poor detoxification capacity and decreased protein content of Glo1 in a murine CamKIIδ knockout model. Therefore, phosphorylation of T107 in the Glo1 protein by CamKIIδ is a quick and precise mechanism regulating Glo1 activity, which is experimentally linked to an altered Glo1 status in cancer, diabetes, and during aging.

1 December 2020 in STAR Protocols
Verified
Journal Article
Open access
JMJakob Morgenstern
Jakob Morgenstern
EKElisabeth Kliemank
Elisabeth Kliemank
MCMarta Campos Campos
Marta Campos Campos
PNPeter Nawroth
Peter Nawroth
TFThomas Fleming
Thomas Fleming
Aldo-keto reductases (AKRs) are responsible for the detoxification of harmful aldehydes. Due to the large number of isotypes, the physiological relevance of AKRs cannot be obtained using mRNA or protein quantification, but only through the use of enzymatic assays to demonstrate functionality. Here, we present a fast and simple protocol to determine the important Michaelis-Menten kinetics of AKRs, which includes various aldehyde substrates of interest such as 4-hydroxynonenal, methylglyoxal, and malondialdehyde.

10 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
JMJakob Morgenstern
Jakob Morgenstern
SKSylvia Katz
Sylvia Katz
JKJutta Krebs-Haupenthal
Jutta Krebs-Haupenthal
JCJessy Chen
Jessy Chen
ASAlireza Saadatmand
Alireza Saadatmand
TFThomas Fleming
Thomas Fleming
The glyoxalase system is a ubiquitously expressed enzyme system with narrow substrate specificity and is responsible for the detoxification of harmful methylglyoxal (MG), a spontaneous by-product of energy metabolism. Glyoxalase 1 (Glo1) is the first and therefore rate limiting enzyme of this protective system. In this study we were able to show that a phosphorylation of threonine-107 in the Glo1 protein, mediated by Ca 2+ /Calmodulin-dependent Kinase II delta (CamKIIδ), is associated with elevated catalytic efficiency of Glo1. In fact, Michaelis-Menten kinetics of Glo1 mutants revealed that a permanent phosphorylation of Glo1 was associated with increased V max (1.23 µmol/min/mg) and decreased K m (0.19 mM HTA), whereas the non-phosphorylatable Glo1 showed significantly lower V max (0.66 µmol/min/mg) and increased K m (0.31 mM HTA). This was also confirmed with human recombinant Glo1 (V max (Glo1 phos ) = 999 µmol/min/mg; K m (Glo1 phos ) = 0.09 mM HTA vs. V max (Glo1 red ) = 497 µmol/min/mg; K m (Glo1 red ) = 0.12 mM HTA). Additionally, proteasomal degradation of non-phosphorylated Glo1 via ubiquitination occurred more rapidly as compared to native Glo1. The absence of the responsible kinase CamKIIδ was associated with poor MG detoxification capacity and decreased protein content of Glo1 in a murine CamKIIδ knock-out model. Furthermore, this regulatory mechanism is also related to an altered Glo1 status in cancer, diabetes and during aging. In summary, phosphorylation of threonine-107 in the Glo1 protein by CamKIIδ is a quick and precise mechanism regulating Glo1 activity.